This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)
Clinical trial NCT02859909 · COMPLETED
Trial details
- NCT number
- NCT02859909
- Sponsor
- Biotest
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-12-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.